3647 results for «629»
3647 results
Lifetime management of TAVI patient
15 Dec 2021 – From GulfPCR-GIM 2021
In this session, start viewing the case of a 67-year-old female patient with hypertension and severe symptomatic aortic stenosis used to illustrate TAVI in very small aortic annulus, and, then, follow the discussion about smallest annulus treated with TAVI and lifetime management of TAVI patient.
Challenging Cases
15 Dec 2021 – From GulfPCR-GIM 2021
This session comprises a series of cases presenting complications to be discussed: if you were faced with them, what would be your strategy? Watch it and compare your methods with the ones of your peers!
GulfPCR-GIM 2021 Opening Ceremony
15 Dec 2021 – From GulfPCR-GIM 2021
Listen to the enthusiastic speeches of the 4 Course Directors who are happy to open this 10th edition of the GulfPCR-GIM Congress and to present the main highlights of a program that promises to be dense and rich.
Mitral valve disease: state-of-the-art
21 Nov 2021 – From PCR London Valves 2021
Did you ever wonder what an expert surgeon can achieve today in mitral repair? Have you ever wondered when to treat an asymptomatic patient with severe mitral regurgitation? These are some of the questions this session from PCR London Valves 2021 will try to answer.
DK crush technique in a calcified LAD-diagonal bifurcation - LIVE case
Recommended by PCR
20 May 2026 – From EuroPCR 2026
A 53‑year‑old man with hypertension and dyslipidemia presented with an inferior MI treated with primary PCI of the RCA two months earlier. He was referred for staged treatment of a significant calcified LAD–diagonal bifurcation lesion. Lesion preparation included non‑compliant balloon dilatation, rotational atherectomy in the LAD...
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)
31 Mar 2025
Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.
The manuscript for this trial has not been published and all assumptions are based upon the presentation.
Author
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
